Document is current
Any future updates will be listed below
-
Authors
Mouliere, Florent https://orcid.org/0000-0001-7043-0514
Smith, Christopher G https://orcid.org/0000-0001-7357-2737
Heider, Katrin
Su, Jing
van der Pol, Ymke https://orcid.org/0000-0002-3040-5848
Thompson, Mareike
Morris, James
Wan, Jonathan C M
Chandrananda, Dineika https://orcid.org/0000-0002-8834-9500
Hadfield, James
Grzelak, Marta
Hudecova, Irena
Couturier, Dominique‐Laurent
Cooper, Wendy https://orcid.org/0000-0003-3416-9982
Zhao, Hui
Gale, Davina https://orcid.org/0000-0002-4521-8199
Eldridge, Matthew
Watts, Colin
Brindle, Kevin https://orcid.org/0000-0003-3883-6287
Rosenfeld, Nitzan https://orcid.org/0000-0002-2825-4788
Mair, Richard https://orcid.org/0000-0001-8235-5689
-
Funding
Funding for this research was provided by:
Cancer Research UK (A20240)
Cancer Research UK (A29580)
Cancer Research UK (A17197)
Cancer Research UK (A16465)
FP7 Ideas: European Research Council (337905)
KWF Kankerbestrijding (12822)
- License Information
-
More Information
Article History
Received: 4 June 2020
Revised: 12 June 2021
Accepted: 14 June 2021
First Online: 22 July 2021
Conflict of interest
: N.R. and D.G. are co‐founders, present/former officers or consultants and/or shareholders of Inivata Ltd, a cancer genomics company that commercializes circulating DNA analysis. C.G.S. has consulted for Inivata Ltd. Inivata had no role in the conception, design, data collection, and analysis of the study. Patent applications may be filed describing additional methods described in the manuscript. Other co‐authors have no conflict of interests.
